Effect of candesartan on recurrence of esophageal varices after endoscopic therapy with hypertension.

Trial Profile

Effect of candesartan on recurrence of esophageal varices after endoscopic therapy with hypertension.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 27 Aug 2014

At a glance

  • Drugs Calcium channel antagonists; Candesartan cilexetil
  • Indications Hypertension
  • Focus Pharmacodynamics
  • Most Recent Events

    • 16 Aug 2014 Status changed from recruiting to discontinued as reported by University Hospital Medical Information Network - Japan record UMIN000002088 .
    • 24 Jun 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top